Regular blood testing to check for toxicity from standard rheumatoid arthritis drugs is recommended. Results of this ...

Crescendo Bioscience, creators of the Vectra DA blood test to predict the progression of rheumatoid arthritis (RA), is gaining market share in the United States, with its new parent company ...

Equipped with a blood test capable of predicting an individual’s response—or lack thereof—to the world’s largest drug class, Scipher Medicine is on its way to cracking the code of ...

HealthDay News — For patients with rheumatoid arthritis (RA) using disease-modifying antirheumatic drugs (DMARDs), long-term routine laboratory toxicity monitoring (lt-RLTM) indicates that most very ...

Results presented today at the American College of Rheumatology in Boston show that a 12-biomarker test did a better job of predicting radiographic progression in patients with RA. The study ...

This test will very likely be one of the first tests your rheumatologist runs when an inflammatory form of arthritis like rheumatoid arthritis is suspected. -- Anti-Cyclic Citrullinated Peptide.

Science X Science News Wire : Blood test for rheumatoid arthritis treatment is 'first step towards a better future' for patients -- a press release is provided to you ìas isî with little or no review ...

When it comes to informing treatment decisions, rheumatologists value patient-reported symptoms and physical function over physical findings and test results, according to group polling results.

RHEUMATOID ARTHRITIS is a type of autoimmune disease where the body's immune system attacks the lining of the joints - but what are the key symptoms that could indicate early signs of this ...

For patients with rheumatoid arthritis (RA) using disease-modifying antirheumatic drugs (DMARDs), long-term routine ...